Statins may increase risk of diabetes by 46 percent
the ONA take:
The use of statins is associated with a 46% increase in the risk of developing diabetes, a new study published in the journal Diabetologia has shown.
For the study, researchers from the University of Eastern Finland and Kuopio University Hospital in Finland sought to investigate the effects of statin treatment on the risk of type 2 diabetes and blood sugar control in non-diabetic men that participated in the 6-year follow-up of the Metabolic Syndrome in Men (METSIM) study.
Among the 8,749 participants, 625 were diagnosed with new diabetes during the 5.9-year followw-up period.
Results showed that after adjusting for confounding factors, such as BMI, physical activity, alcohol intake, smoking, and beta-blocker and diuretic use, patients who took statins were 46% more likely to develop diabetes compared with those who were not treated with diabetes.
Researchers found that the high-dose simvastatin was associated with a 46% increased risk of developing diabetes compared with 28% increased risk for low-dose simvastatin. High-dose atorvastatin was associated with a 37% increased risk.
The use of statins is associated with a 46% increase in the risk of developing diabetes.
- Novel Colonoscopy Prep Is Poised to Improve Screening Rates for Colon Cancer
- Short-Term Intervention May Have Long-term Diet Effect in Hispanic Breast Cancer Survivors
- Childhood Cancer Linked to Poor Diet Quality in Adult Survivors
- Low-Dose Sublingual Fentanyl Safe, Effective in Patients Receiving Lower Opioid Doses
- Panobinostat Modestly Improves OS in Relapsed Multiple Myeloma
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Implementing a Distress Screening Process for Cancer Patients
- Initiating Palliative Care in the Emergency Department
- Recurrence Score Appears To Be Driving Personalized Treatment for Breast Cancer
- Smoking-related Cancer Deaths Highest in Southern United States
- Study Suggests More Men With Prostate Cancer Would Choose Active Surveillance if it Were Offered
- The Bounty of Failure: A Well-Versed Nursing Experience
- Olaratumab in Combo With Doxorubicin Approved for Soft Tissue Sarcoma
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|